{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:15:33Z","timestamp":1792275333854,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,3,15]],"date-time":"2011-03-15T00:00:00Z","timestamp":1300147200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2407-11-95","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T19:19:35Z","timestamp":1300303175000},"source":"Crossref","is-referenced-by-count":34,"title":["Validation of prognostic scores for survival in cancer patients beyond first-line therapy"],"prefix":"10.1186","volume":"11","author":[{"given":"Olivier","family":"Tr\u00e9dan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ray-Coquard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gis\u00e8le","family":"Chvetzoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rebattu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Bajard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Chabaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"P\u00e9rol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chadi","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Quiblier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Blay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bachelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,15]]},"reference":[{"key":"2587_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/bmj.327.7408.195","volume":"327","author":"P Glare","year":"2003","unstructured":"Glare P, Virik K, Jones M, Hudson M, Eychmuller S, Simes J, Christakis N: A systematic review of physicians' survival predictions in terminally ill cancer patients. Br Med J. 2003, 327: 195-198. 10.1136\/bmj.327.7408.195.","journal-title":"Br Med J"},{"key":"2587_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1001\/jama.290.1.98","volume":"290","author":"E Lamont","year":"2003","unstructured":"Lamont E, Christakis N: Complexities in prognostication in advanced cancer: \"to help them live their lives the way they want to\". JAMA. 2003, 290: 98-104. 10.1001\/jama.290.1.98.","journal-title":"JAMA"},{"key":"2587_CR3","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.1200\/JCO.2005.06.866","volume":"23","author":"M Maltoni","year":"2005","unstructured":"Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, Glare P, Nabal M, Vigan\u00f2 A, Larkin P, De Conno F, Hanks G, Kaasa S, Steering Committee of the European Association for Palliative Care: Prognostic factors in advanced cancer patients: evidence-based clinical recommendations - a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol. 2005, 23: 6240-6248. 10.1200\/JCO.2005.06.866.","journal-title":"J Clin Oncol"},{"key":"2587_CR4","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.1200\/JCO.2004.12.056","volume":"22","author":"PA Glare","year":"2004","unstructured":"Glare PA, Eychmueller S, McMahon P: Diagnostic accuracy of the Palliative Prognostic Score in hospitalized patients with advanced cancer. J Clin Oncol. 2004, 22: 4823-4828. 10.1200\/JCO.2004.12.056.","journal-title":"J Clin Oncol"},{"key":"2587_CR5","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1200\/JCO.1999.17.9.2840","volume":"17","author":"I Ray-Coquard","year":"1999","unstructured":"Ray-Coquard I, Le Cesne A, Rubio MT, Mermet J, Maugard C, Ravaud A, Chevreau C, Sebban C, Bachelot T, Biron P, Blay JY: Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group. J Clin Oncol. 1999, 17: 2840-2846.","journal-title":"J Clin Oncol"},{"key":"2587_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1023\/A:1008368319526","volume":"11","author":"T Bachelot","year":"2000","unstructured":"Bachelot T, Ray-Coquard I, Catimel G, Ardiet C, Guastalla JP, Dumortier A, Chauvin F, Droz JP, Philip T, Clavel M: Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials. Ann Oncol. 2000, 11: 151-156. 10.1023\/A:1008368319526.","journal-title":"Ann Oncol"},{"key":"2587_CR7","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1054\/bjoc.2001.2011","volume":"85","author":"I Ray-Coquard","year":"2001","unstructured":"Ray-Coquard I, Ghesqui\u00e8re H, Bachelot T, Borg C, Biron P, Sebban C, LeCesne A, Chauvin F, Blay JY, ELYPSE Study Group: Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas. Br J Cancer. 2001, 85: 816-822. 10.1054\/bjoc.2001.2011.","journal-title":"Br J Cancer"},{"key":"2587_CR8","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/sj.bjc.6600956","volume":"88","author":"T Bachelot","year":"2003","unstructured":"Bachelot T, Ray-Coquard I, Menetrier-Caux C, Rastkha M, Duc A, Blay JY: Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Cancer. 2003, 88: 1721-1726. 10.1038\/sj.bjc.6600956.","journal-title":"Br J Cancer"},{"key":"2587_CR9","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1200\/JCO.2004.06.121","volume":"22","author":"S Negrier","year":"2004","unstructured":"Negrier S, Perol D, Menetrier-Caux C, Escudier B, Pallardy M, Ravaud A, Douillard JY, Chevreau C, Lasset C, Blay JY, Groupe Francais d'Immunotherapie: Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6, from the Groupe Francais d'Immunoth\u00e9rapie. J Clin Oncol. 2004, 22: 2371-2378. 10.1200\/JCO.2004.06.121.","journal-title":"J Clin Oncol"},{"key":"2587_CR10","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1002\/cncr.20688","volume":"101","author":"C Borg","year":"2004","unstructured":"Borg C, Ray-Coquard I, Philip I, Clapisson G, Bendriss-Vermare N, Menetrier-Caux C, Sebban C, Biron P, Blay JY: CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer. Cancer. 2004, 101: 2675-2680. 10.1002\/cncr.20688.","journal-title":"Cancer"},{"key":"2587_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1207\/s15327914nc4802_6","volume":"48","author":"MM Elahi","year":"2004","unstructured":"Elahi MM, McMillian DC, McArdle CS, Angerson WJ, Sattar N: Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer. Nutr Cancer. 2004, 48: 171-173. 10.1207\/s15327914nc4802_6.","journal-title":"Nutr Cancer"},{"key":"2587_CR12","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1038\/sj.bjc.6602591","volume":"92","author":"LM Forrest","year":"2005","unstructured":"Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dagg K, Scott HR: A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2005, 92: 1834-1836. 10.1038\/sj.bjc.6602591.","journal-title":"Br J Cancer"},{"key":"2587_CR13","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1158\/1078-0432.CCR-07-1044","volume":"14","author":"LA Hefler","year":"2008","unstructured":"Hefler LA, Concin N, Hofstetter G, Marth C, Mustea A, Sehouli J, Zeillinger R, Leipold H, Lass H, Grimm C, Tempfer CB, Reinthaller A: Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer. Clin Cancer Res. 2008, 14: 710-714. 10.1158\/1078-0432.CCR-07-1044.","journal-title":"Clin Cancer Res"},{"key":"2587_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/sim.4780080704","volume":"8","author":"FY Hsieh","year":"1989","unstructured":"Hsieh FY: Sample size tables for logistic regression. Stat Med. 1989, 8: 795-802. 10.1002\/sim.4780080704.","journal-title":"Stat Med"},{"key":"2587_CR15","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.1200\/JCO.2008.17.1363","volume":"26","author":"E Chow","year":"2008","unstructured":"Chow E, Abdolell M, Panzarella T, Harris K, Bezjak A, Warde P, Tannock I: Predictive model for survival in patients with advanced cancer. J Clin Oncol. 2008, 26: 5863-5869. 10.1200\/JCO.2008.17.1363.","journal-title":"J Clin Oncol"},{"key":"2587_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE, Lee KL, Mark DB: Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996, 15: 361-387. 10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4.","journal-title":"Stat Med"},{"key":"2587_CR17","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/sim.1621","volume":"23","author":"P Royston","year":"2004","unstructured":"Royston P, Sauerbrei W: A new measure of prognostic separation in survival data. Stat Med. 2004, 23: 723-748. 10.1002\/sim.1621.","journal-title":"Stat Med"},{"key":"2587_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10549-006-9224-x","volume":"100","author":"R Asola","year":"2006","unstructured":"Asola R, Huhtala H, Holli K: Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer. Breast Cancer Res Treat. 2006, 100: 77-82. 10.1007\/s10549-006-9224-x.","journal-title":"Breast Cancer Res Treat"},{"key":"2587_CR19","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/pon.1140","volume":"16","author":"S Braga","year":"2007","unstructured":"Braga S, Miranda A, Fonseca R, Passos-Coelho JL, Fernandes A, Costa JD, Moreira A: The aggressiveness of cancer care in the last three months of life: a retrospective single centre analysis. Psychooncology. 2007, 16: 863-868. 10.1002\/pon.1140.","journal-title":"Psychooncology"},{"key":"2587_CR20","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/S0360-3016(02)02832-8","volume":"53","author":"E Chow","year":"2002","unstructured":"Chow E, Fung K, Panzarella T, Bezjak A, Danjoux C, Tannock I: A predictive model for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinic. Int J Radiat Oncol Biol Phys. 2002, 53: 1291-1302. 10.1016\/S0360-3016(02)02832-8.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2587_CR21","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1158\/0008-5472.CAN-08-3845","volume":"69","author":"I Ray-Coquard","year":"2009","unstructured":"Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, Tredan O, Verweij J, Biron P, Labidi I, Guastalla JP, Bachelot T, Perol D, Chabaud S, Hogendoorn PC, Cassier P, Dufresne A, Blay JY, European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group: Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res. 2009, 69: 5383-2391. 10.1158\/0008-5472.CAN-08-3845.","journal-title":"Cancer Res"},{"key":"2587_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/0885-3924(92)90118-2","volume":"7","author":"E Bruera","year":"1992","unstructured":"Bruera E, Miller MJ, Kuehn N, MacEachern T, Hanson J: Estimate of survival of patients admitted to a palliative care unit: A prospective study. J Pain Symptom Manage. 1992, 7: 82-86. 10.1016\/0885-3924(92)90118-2.","journal-title":"J Pain Symptom Manage"},{"key":"2587_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10549-007-9550-7","volume":"107","author":"A Dufresne","year":"2008","unstructured":"Dufresne A, Pivot X, Tournigand C, Facchini T, Altweegg T, Chaigneau L, De Gramont A: Impact of chemotherapy beyond the first line in patients with metastatic breast cancer. Breast Cancer Res Treat. 2008, 107: 275-279. 10.1007\/s10549-007-9550-7.","journal-title":"Breast Cancer Res Treat"},{"key":"2587_CR24","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1001\/archinte.1988.00380070082020","volume":"148","author":"DB Reuben","year":"1988","unstructured":"Reuben DB, Mor V, Hiris J: Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med. 1988, 148: 1586-1591. 10.1001\/archinte.148.7.1586.","journal-title":"Arch Intern Med"},{"key":"2587_CR25","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/1097-0142(19950515)75:10<2613::AID-CNCR2820751032>3.0.CO;2-1","volume":"75","author":"M Maltoni","year":"1995","unstructured":"Maltoni M, Pirovano M, Scarpi E, Marinari M, Indelli M, Arnoldi E, Gallucci M, Frontini L, Piva L, Amadori D: Prediction of survival of patients terminally ill with cancer: Results of an Italian prospective multicentric study. Cancer. 1995, 75: 2613-2622. 10.1002\/1097-0142(19950515)75:10<2613::AID-CNCR2820751032>3.0.CO;2-1.","journal-title":"Cancer"},{"key":"2587_CR26","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1200\/JCO.1996.14.2.636","volume":"14","author":"JY Blay","year":"1996","unstructured":"Blay JY, Chauvin F, Le Cesne A, Anglaret B, Bouhour D, Lasset C, Freyer G, Philip T, Biron P: Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia. J Clin Oncol. 1996, 14: 636-639.","journal-title":"J Clin Oncol"},{"key":"2587_CR27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1182\/blood.V92.2.405","volume":"92","author":"JY Blay","year":"1998","unstructured":"Blay JY, Le Cesne A, Mermet C, Maugard C, Ravaud A, Chevreau C, Sebban C, Guastalla J, Biron P, Ray-Coquard I: A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapy. Blood. 1998, 92: 405-410.","journal-title":"Blood"},{"key":"2587_CR28","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1200\/JCO.2006.10.5411","volume":"25","author":"S Gripp","year":"2007","unstructured":"Gripp S, Moeller S, B\u00f6lke E, Schmitt G, Matuschek C, Asgari S, Asgharzadeh F, Roth S, Budach W, Franz M, Willers R: Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol. 2007, 25: 3313-3320. 10.1200\/JCO.2006.10.5411.","journal-title":"J Clin Oncol"},{"key":"2587_CR29","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/j.1742-1241.2004.00169.x","volume":"58","author":"H Bozcuk","year":"2004","unstructured":"Bozcuk H, Koyuncu E, Yildiz M, Samur M, Ozdogan M, Arta\u00e7 M, Coban E, Savas B: A simple and accurate prediction model to estimate the intrahospital mortality risk of hospitalised cancer patients. Int J Clin Pract. 2004, 58: 1014-1019. 10.1111\/j.1742-1241.2004.00169.x.","journal-title":"Int J Clin Pract"},{"key":"2587_CR30","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jpainsymman.2007.06.001","volume":"34","author":"N Kikuchi","year":"2007","unstructured":"Kikuchi N, Ohmori K, Kuriyama S, Shimada A, Nakaho T, Yamamuro M, Tsuji I: Survival prediction of patients with advanced cancer: the predictive accuracy of the model based on biological markers. J Pain Symptom Manage. 2007, 34: 600-606. 10.1016\/j.jpainsymman.2007.06.001.","journal-title":"J Pain Symptom Manage"},{"key":"2587_CR31","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.ejca.2007.01.031","volume":"43","author":"SY Suh","year":"2007","unstructured":"Suh SY, Ahn HY: Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: a preliminary study. Eur J Cancer. 2007, 43: 1051-1059. 10.1016\/j.ejca.2007.01.031.","journal-title":"Eur J Cancer"},{"key":"2587_CR32","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jpainsymman.2007.06.001","volume":"34","author":"N Kikuchi","year":"2007","unstructured":"Kikuchi N, Ohmori K, Kuriyama S, Shimada A, Nakaho T, Yamamuro M, Tsuji I: Survival prediction of patients with advanced cancer: the predictive accuracy of the model based on biological markers. J Pain Symptom Manage. 2007, 34: 600-6. 10.1016\/j.jpainsymman.2007.06.001.","journal-title":"J Pain Symptom Manage"},{"key":"2587_CR33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0895-4356(97)00015-2","volume":"50","author":"P Goldwasser","year":"1997","unstructured":"Goldwasser P, Feldman J: Association of serum albumin and mortality risk. J Clin Epidemiol. 1997, 50: 693-703. 10.1016\/S0895-4356(97)00015-2.","journal-title":"J Clin Epidemiol"},{"key":"2587_CR34","first-page":"3317","volume":"52","author":"JY Blay","year":"1992","unstructured":"Blay JY, Negrier S, Combaret V, Attali S, Goillot E, Merrouche Y, Mercatello A, Ravault A, Tourani JM, Moskovtchenko JF, Philip T, Favrot M: Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res. 1992, 52: 3317-22.","journal-title":"Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-95.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-11-95\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-95","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T10:56:46Z","timestamp":1592391406000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-11-95"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,15]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["2587"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-11-95","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,15]]},"article-number":"95"}}